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Mink enteritis virus (MEV) is one of the most important pathogens in the mink industry. Recent studies have shed light
into the role of microRNAs (miRNAs), small noncoding RNAs of length ranging from 18–23 nucleotides (nt), as critical
modulators in the host-pathogen interaction networks. We previously showed that miRNA miR-181b can inhibit MEV
replication by repression of viral non-structural protein 1 expression. Here, we report that two other miRNAs (miR-320a
and miR-140) inhibit MEV entry into feline kidney (F81) cells by downregulating its receptor, transferrin receptor (TfR),
by targeting the 3′ untranslated region (UTR) of TfR mRNA, while being themselves upregulated.
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Mink enteritis virus (MEV) is an autonomous parvovirus
that causes important disease in mink, leading to huge eco-
nomic losses worldwide. MEV is a single-stranded negative
sense DNA virus belonging to the family Parvoviridae,
with a genome of about 5 kb containing 2 main open read-
ing frames (ORFs). MEV, a variant of feline panleukopenia
virus (FPV) and highly homologous with canine parvovirus
(CPV), causes a highly infectious acute disease of mink
characterized by extensive virus replication in mesenteric
lymph nodes and intestinal crypt epithelial cells, with an
associated loss of intestinal mucosa, diarrhea, and a high
rate of morbidity and mortality [1-5].
MicroRNAs (miRNAs) are endogenous and highly con-
served small noncoding RNAs of length 18–23 nucleotides
(nt), which have gained widespread attention as critical
modulators in many biological processes including cell
proliferation and differentiation, development and apop-
tosis. In animals, miRNAs are imprecisely complimentary
to their mRNA targets and act by repression of target gene
expression [6-9].* Correspondence: weiquan8@cau.edu.cn
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unless otherwise stated.Attention has also been paid to the role of miRNAs as ef-
fectors in host-virus interaction networks [10,11], either by
targeting cellular factors useful for virus replication [12,13]
or by directly targeting virus mRNAs [14-17]. We have re-
cently reported that a cellular miRNA miR-181b inhibits
MEV infection by repression of viral non-structural protein
1 expression [18], which indicates that cellular miRNAs
may play a direct role on viral mRNAs themselves.
For many animal viruses, cell entry and infection are ini-
tiated by receptor-mediated endocytosis involving specific
cellular surface components. Transferrin receptor (TfR), is
required for the import of iron into the cell, and is regu-
lated by intracellular iron concentration. It has also been
reported to be a receptor for MEV, controlling the first
step in the viral infection process. TfR can be considered a
model for the endocytosis and recycling of receptor-ligand
complexes: it is excluded from lipid raft domains in the
plasma membrane and is taken up rapidly from the cell
surface via clathrin-mediated endocytosis [1,19-24]. Since
TfR plays an important role in MEV infection, we there-
fore investigated whether miRNAs participate in the host-
virus interaction by modulating its activity.Materials and methods
Cell culture and MEV infection
Feline F81 cells, obtained from the American Type
Culture Collection (ATCC), were cultured as monolayers. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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taining 10% FBS (Hyclone, Logan, UT), and 1% penicillin-
streptomycin (Gibco) at 37°C in a 5% CO2 atmosphere.
MEV strain L was originally isolated from an infected ani-
mal in a mink farm, Liaoning province, China. The whole
viral genome has been sequenced in our laboratory and
found to have high identity with MEV strain Abashiri
(GenBank accession, D00765.1). For infection, F81 cell
monolayers were first dispersed by 0.25% trypsin and virus
was added to the suspension before incubation in the ori-
ginal plates.
Deep sequencing of small RNAs and analysis of the
sequencing data [25]
F81 cells cultured in 6-well plates (Costar) were infected
with MEV at an input multiplicity (MOI) of 1 pfu/cell. Un-
infected cells were maintained as a control. Twenty-four h
later, the triplicate cultures were pooled, total RNA was
extracted by Trizol reagent (Invitrogen) and small RNAs
with length of 18–30 nt were separated by PAGE. Ten μg
samples of the isolated RNAs were submitted to Solexa
(Illumina) for sequencing as cDNA libraries. Duplicate se-
quences were eliminated from the initial data set. The
resulting sets of unique reads were mapped onto the feline
genome [26,27] using the program Short Oligonucleotide
Analysis Package (SOAP) [28]. Perfectly matched reads
were also mapped onto the miRNAs of six reference
species (Homo sapiens, Canis familiaris, Mus musculus,
Rattus norvegicus, Bos taurus and Sus scrofa) listed in the
Sanger miRBase (Release 18) using the Patscan tool [29]
to identify homologs of known miRNAs.
Prediction of miRNA targets in feline TfR mRNA 3′UTR
RNAhybrid tools (http://bibiserv.techfak.uni-bielefeld.de/
rnahybrid/submission.html/) [30] were used to predict
miRNA targets in TfR mRNA 3′UTR following the rules
of no mismatch and G/U complementarity in miRNA seed
sequences. RegRNA tools (http://vita.mbc.nctu.edu.tw/)
[31] were also used to predict regulatory RNA motifs in
the TfR mRNA 3′UTR. TargetScan (http://www.targetscan.
org/) tools were used to predict conservative miRNA tar-
gets in the TfR mRNA 3′UTRs of different species.
Plasmid construction
The luciferase expression vector pGL3-control (Promega)
was used for construction of predicted miRNA candidate
targets containing a luciferase reporter gene, with pRL-TK
(Promega) as control. Sequences containing part of the
TfR 3′UTR and candidate targets of miRNAs were ampli-
fied by RT-PCR and directionally inserted into the 3′UTR
of the luciferase gene in the pGL3-control vector, gene-
rating pGL3-TfR 3′UTR. To facilitate cloning, the first
PCR product amplified by the first pair of primers
(5′-ATGTGGTACCTATACTTATATGAGAAC-3′ and 5′-TCCGTGTTCAAGCATTTTATTAAATC-3′) was used
as a template and an Xba I restriction site (italics) was
added to the 5’- (5′-GCTCTAGAATGTGGTACCTAT
ACTTATATGAGAACAGC-3′) and 3′- (5′-GCTCTAGA
TCCGTGTTCAAGCATTTTATTAAATCAG-3′) second-
ary pair of primers. To further ascertain that the binding
sites of the predicted miRNAs in TfR 3′UTR indeed
existed, tetranucleotide mutations were generated in the
two potential target sites of pGL3-TfR 3′UTR using PCR,







TGAAG-3′). Mutant plasmids were generated by PCR
using PrimeSTAR MAX DNA Polymerase (TaKaRa), 50
ng of the parent vectors as templates and the complemen-
tary primers under the following conditions: 98°C for 3
min, followed by 30 cycles of 98°C for 10 s, 55°C for 15 s
and 72°C for 90 s, followed by 72°C 10 min. The resulting
products were digested with 1 μl Dpn-1 for 1 h at 37°C to
remove the parental DNA. The remaining DNA was used
to transform competent DH5α cells, and a number of col-
onies containing mutant plasmids were obtained and con-
firmed by sequencing (Shanghai Sangong Co.).
miRNA mimics and inhibitors
The miR-320a, miR-320b, miR-140, miR-145, miR-152,
miR-182 and miR-194 mimics and inhibitors, mut miR-
320 mimics (in which the tetranucleotide mutation was
complementary to mut320 pGL3-TfR 3′UTR) and mut
miR-140 mimics (in which the tetranucleotide mutation
was complementary to mut140 pGL3-TfR 3′UTR) were
synthesized by GenePharma, Shanghai. All mimics were
double-stranded RNA oligos, while inhibitors were single-
stranded. Negative control mimics and inhibitors were
also synthesized for control experiments. The inhibitors
were modified by 2′-O-methylation. All sequences of






























Mut miR-320a mimics: 5′-AAUUCGUGGGUUGAGA
GGGCGA-3′
Mut miR-140 mimics: 5′-CACACCUUUUACCCUAU
GGUAG-3′
Negative control (NC) mimics: 5′-UUCUCCGAACGU
GUCACGUTT-3′
Negative control (NC) inhibitors: 5′-CAGUACUUUU
GUGUAGUACAA-3′
Transfection
To screen for selected miRNAs to downregulate the ex-
pression of TfR, F81 cells, at a confluence of 60-70% in
24-well plates (Costar), were transfected with mimics or
inhibitors (10 nM) using Lipofectamine 2000 transfec-
tion reagent (Invitrogen). NC mimics and inhibitors
were used as controls. To further determine whether the
screened miRNAs could modulate the expression of TfR,
F81 cells were transfected with the mimics in a dose-
dependent manner. The cells were collected for TfR
mRNA qPCR assay at 36 h post-transfection and west-
ern blot analysis and flow cytometry assay at 48 h.
To determine whether the selected miRNAs play a dir-
ect role in repression of luciferase expression from
pGL3-TfR 3′UTR, 24-well plates seeded with F81 cells
at 60-70% confluence were co-transfected with a mixture
of pGL3-TfR 3′UTR (4 μg/ml) and pRL-TK vector
(4 μg/ml) together with mimics (10 nM). The mut320a
or mut140 pGL3-TfR 3′UTR and pRL-TK together with
mimics (10 nM) were co-transfected to verify accuracy
of the seed sequence. NC mimics were used as negative
controls. After 36 h, the cells were harvested for relative
luciferase activity assay.
To determine the effects of the selected miRNAs on
MEV infection, F81 cells, at a confluence of 60-70% in
24-well plates, were transfected with mimics (10 nM).
After 48 h, the cells were dispersed with 0.25% trypsin
and infected with MEV (MOI = 0.1). Virus infection was
measured by qPCR and flow cytometric analysis at the
indicated times.Luciferase assays
To quantify the relative luciferase activity, a dual-luciferase
reporter assay system kit (Promega) was used according to
the manufacturer’s protocol. Co-transfected cells with a
mixture of luciferase reporter plasmids were washed with
cold phosphate-buffered saline (PBS). Passive lysis buffer
(Promega: 100 μl) was then added to the cells in each well.
After 10 min, the supernatants were clarified by centrifu-
gation at 12,000 g for 30 s, and the luciferase activity was
measured using a Modulus single-tube multimode reader
(Promega). Relative luciferase expression was calculated as
the expression of firefly luciferase (pGL3-control vector)
divided by that of Renilla luciferase (pRL-TK).
Real-time quantitative PCR (qPCR) analysis
To detect whether selected miRNAs can downregulate the
expression of TfR, qPCR analysis was performed. After
transfection of F81 cells with miRNA mimics or inhibitors,
NC mimics or inhibitors as controls, total RNA was ex-
tracted and digested with DNase I (Takara). Two μg total
RNA of each sample was reverse transcribed using M-
MLV reverse transcriptase (Promega) according to the
manufacturer’s protocol. The β-actin mRNA level was
measured as a control. Primers used for amplification
were: β-actin, 5′-CGGGACCTGACGGACTACCT-3′ and
5′-GGCCATCTCCTGCTCAAAAT-3′ and TfR, 5′-ATG
ATTGGCTACTTGGGCTATTG-3′ and 5′-CCTGATGG
TGCTGGTGAACTC-3′.
To detect the viral genomic DNA quantitative level in
F81 cells, total DNA was extracted and the concentration
was measured. PCR amplication of a fragment of viral
genomic DNA (5′-GCTTACGCTGCTTATCTTCGC-3′,
5′-TAATGTCCTATTTTCCCCCCC-3′) was performed.
To determine the expression level of miRNAs in F81
cells, total RNA was extracted, and 2 μg was polyadeny-
lated using E. coli poly (A) polymerase according to the
manufacturer’s protocol (Promega). The poly (A) reac-
tion product was then reverse transcribed using M-MLV
reverse transcriptase (Promega) and an adaptor primer
[32] (5′-GCGAGCACAGAATTAATACGACTCACTAT
AGGTTTTTTTTTTTTVN-3′) according to the manu-
facturer’s protocol. PCR amplication was carried out using
the specific miRNAs primers (miR-320a, 5′-AAAAGCG
GGGAGAGGGCG-3′ and 5′-GCGAGCACAGAATTAAT
ACGACTCAC-3′ and miR-140, 5′-CAGTGGTTTTACC
CTATGGTAGAAA-3′ and 5′-GCGAGCACAGAATTAA
TACGACTCAC-3′). U6 small RNA expression level
was measured as a control using primers 5′-CTCGCTT
CGGCAGCACA-3′ and 5′-AACGCTTCACGAATTTG
CGT-3′. Cycling conditions for qPCR using FastSYBR
Mixture (CWBIO) and the ViiA™ 7 real-time PCR System
(Applied Biosystems) were 95°C for 20 s, followed by 35 -
cycles of 95°C for 3 s and 60°C for 30 s. The data were ana-
lyzed by the ΔΔCt method [33].
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F81 cells transfected with mimics in a 24-well plate were
washed 3 times with cold PBS, a mixture of 100 μl RIPA
lysis buffer (HX-BIO) and 0.5 mM PSMF was added and
the cells were harvested into Eppendorf tubes. After
30 min on ice and centrifugation at 12,000 g for 30 min,
25 μl supernatant was mixed with 25 μl each 2 × SDS sam-
ple buffer and boiled for 5 min. Samples were subjected to
10% SDS-PAGE gel and transferred to a nitrocellulose
membrane (PALL Life Science). The membranes were
blocked with 5% nonfat dry milk for 1 h, then incubated
for 1 h at room temperature with purified primary mouse
antibody CD71 (H68.4) (Santa Cruz: 1:500 dilution) or
anti-β-actin antibody (MBL: 1:1,000 dilution) in nonfat
milk. After 3 washes with Tris-buffered saline containing
0.05% Tween-20 (TBST), the membranes were incubated
for 1 h at ambient temperature with the appropriate
horseradish peroxidase-conjugated secondary antibody
(MBL: 1:5,000 dilution) in TBST. Protein bands were visu-
alized using ECL western blot substrate (Thermo), with β-
actin as a control.
Flow cytometry
Treated F81 cell monolayers were dispersed with 0.25%
trypsin, harvested and fixed in 4% paraformaldehyde. After
3 washes with PBS and incubation for 1 h at 37°C with
anti-CD71 mouse antibody (1:2500) or anti-MEV rabbit
polyclonal antibody (prepared in this laboratory) at 1:100,
the cells were washed 3 times with PBS, incubated with
fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse or anti-rabbit IgG antibody (MBL: 1:100 dilution)
for 1 h at 37°C, washed another 3 times with PBS and ana-
lysed by BD FACSCalibur flow cytometry. Nonspecific
rabbit polyclonal antibody (iso) (prepared in this labora-
tory) was used as an isotype control. The data were ana-
lyzed using BD CellQuest software.
Argonaute 2 (Ago2) co-immunoprecipitation
Human anti-Ago2 antibody (Abnova) was first bound to
protein A/G-Agarose (Abmart) in PBS for 30 min at 4°C.
Treated F81 cells were harvested, washed and solubilized in
RIPA lysis buffer (HX-BIO) and PSMF for 30 min on ice,
then centrifuged at 12,000 g for 30 min to clarify the super-
natant. The latter was then added to the Ago2/Agarose
conjugate and incubated for 4 h at 4°C. Incubation of the
supernatant with normal mouse IgG (MBL) was used as a
negative control. RNA bound to the Ago2 protein was dis-
sociated with Trizol reagent and reverse transcribed. TfR,
miR-320a and miR-140 were quantified by qPCR analysis,
with β-actin and U6 small RNA as internal controls.
Statistical analysis
Data were analysed statistically using GraphPad software,
as described in the figure legends.Results
Screening of miRNAs targeting TfR mRNA 3′UTR
As described in Materials and Methods, small RNA ultra-
high throughput sequencing was performed (Solexa) on un-
infected F81 cells and following MEV infection (MOI = 1)
to detect miRNAs targeting TfR 3′UTR. Two miRNA li-
braries were also constructed [34]. Screening for miRNAs
with RNAhybrid [30], RegRNA [31] and TargetScan tools
identified 6 miRNA candidates (Figure 1). To test these
miRNAs, F81 cells were transfected with the miRNA
mimics and inhibitors, negative control (NC) mimics and
inhibitors as controls. After 36 h, TfR mRNAs were quanti-
fied by qPCR. Results showed that miR-320a and miR140
mimics decreased TfR mRNA levels by almost 30% com-
pared to NC mimics, and miR-320a inhibitors increased
them approximately 25% (Figure 2A). After 48 h transfec-
tion as above, the quantity of TfR proteins were also exam-
ined by western blot and flow cytometry. Results showed
that miR-320a and miR-140 downregulated the protein
level (Figure 2B) and the percentage of TfR-positive cells by
almost 20% and 30% respectively (Figure 2C). To further
confirm the activity of the mimics, qPCR and western blot
assay were used to show that the expression levels of TfR
were reduced in a dose-dependent manner (Figure 1D,E).
Altogether, these results clearly show that cellular miR-320a
and miR-140 have negative effects on TfR expression.
MEV infection leads to cellular miR-320a and miR-140
upregulation and TfR downregulation
The expression levels of predicted miRNAs are shown in
Table 1. Following MEV infection both miR-320a and
miR-140 showed relatively higher level expression and
greater upregulation than found in uninfected cells. This
was confirmed by qPCR which showed that both miRNAs
gradually increased following MEV infection (Figure 3).
To investigate whether upregulation of the two miRNAs
following MEV infection could affect TfR expression,
qPCR (Figure 3A,B) and western blot (Figure 3C) were
performed simultaneously. As expected, TfR was gradually
downregulated following MEV infection. To further as-
certain that TfR downregulation is the result of miRNAs
upregulation, F81 cells were transfected with miRNA in-
hibitors 12 h post MEV infection. Results showed that
compared with transfection with NC inhibitors, both miR-
320a and miR-140 inhibitors attenuated the inhibitory ef-
fect on TfR expression levels (Figure 3D). It appears,
therefore, that upregulation of miR-320a and miR-140 dir-
ectly results in TfR downregulation.
MiR-320a and miR-140 target the 3′UTR of TfR and
physically bind to TfR mRNA in the RISC
To confirm that miR-320a and miR-140 directly target
TfR 3′UTR and show inhibitory activity, a reporter vec-
tor pGL3-TfR 3′UTR containing the potential target
Figure 1 Screening of miRNAs targeting TfR mRNA 3’UTR in F81 cells. RNAhybrid and TargetScan tools were used to predict miRNA target
sites on TfR mRNA 3′UTR following the rules of no mismatch and G/U complementary in miRNA seed sequences.
Figure 2 MiR-320a and miR-140 inhibits TfR expression in F81 cells. (A) qPCR was used to assess effects of predicted miRNA mimics and
inhibitors on the relative expression of TfR after 36 h transfection with either mimics or inhibitors, with β-actin as an internal control. (B)Western blot
assay was used to assess the TfR protein levels of lysates of F81 cells after 48 h transfection with either mimics or inhibitors. (C) Flow cytometric analysis
was used to assess the percentage of TfR-positive F81 cells after 48 h transfection with miR-320a and miR-140 mimics. (D) qPCR was used to assess the
TfR mRNA levels after 36 h transfection with miR-320a and miR-140 mimics in a dose-dependent manner (E) Western blot assay was used to assess the
TfR protein levels after 48 h transfection with miR-320 and miR-140 mimics in a dose-dependent manner. Data are from 3 independent experiments
(mean ± SD). Statistical significance was analyzed by Student’s t test; *P <0.05; **P <0.01; ns, not significant.
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Table 1 Expression level of the predicted miRNAs of the two libraries
miRNAs Rds numa in mock infected cells Rds num in MEV infected cells TPMb in mock infected cells TPM in MEV infected cells
miR-320a 2432 64835 427.85 11566.02
miR-140 3005 8894 528.66 1586.61
miR-145 1181 668 207.77 119.17
miR-152 1208 561 212.52 100.08
miR-182 3094 5846 544.3 1042.88
miR-194 388 1 68.26 0.18
aRds mum: Reads number.
bTPM: Tags per million.
Sun et al. Virology Journal 2014, 11:210 Page 6 of 12
http://www.virologyj.com/content/11/1/210segment in the 3′UTR of the luciferase gene was con-
structed (Figure 4A). After co-transfection of F81 cells
with pGL3-TfR 3′UTR and miR-320a or miR-140
mimics, the relative luciferase activity was measured. As
predicted, both miR-320a and miR-140 significantly
inhibited the relative luciferase activity (by more than
half ) in comparison with NC mimics (Figure 4B). To
further ascertain the necessary function of complemen-
tary seed sequence, mut320a-pGL3-TfR 3′UTR and
mut140-pGL3-TfR 3′UTR, with mutated tetranucleotides
were constructed and the corresponding mut miR-320a
and mut miR-140 mimics were synthesized (Figure 4A).
As expected, after co-transfection of F81 cells, miR-320a
and miR-140 mimics had no effect on the relative ex-
pression activity of the mutant reporter vector, but mutFigure 3 MEV infection leads to gradual changes of miR-320a, miR-14
expression of miR-320a, miR-140 and TfR mRNAs at the indicated times (A)
internal control. Data are from 3 independent experiments (mean ± SD). (C
normal conditions (−) or after MEV infection (+). (D) Western blot assay wa
miRNA inhibitors post 12 h MEV infection.miR-320a and mut miR-140 mimics downregulated them
by more than 2-fold (Figure 4C,D). To provide evidence
for the physical interaction of the two miRNAs with TfR
mRNA, immunoprecipitation with Argonaute 2 (Ago2)
was performed. As previously described [35], both mRNA
degradation and translation repression is dependent on
RISC, in which the most important factor is Ago2 protein.
Therefore, anti-Ago2 antibody was used to test if the two
miRNAs and TfR mRNA were associated with Ago2. As
expected, when Ago2 protein was specifically precipitated
by anti-Ago2 antibody, as compared with normal IgG, TfR
was enriched more than 3-fold by miR-320a and more
than 2-fold by miR-140 after transfection with miR-320a
or miR-140 mimics respectively, whereas following trans-
fection with mut miR-320a or mut miR-140, TfR was not0 and TfR in F81 cells. qPCR was used to assess the relative
under normal conditions or (B) after MEV infection, with β-actin as an
) Western blot assay was used to assess the TfR expression levels under
s used to assess the TfR expression levels when transfection with
Figure 4 MiR-320a and miR-140 target the 3′UTR of TfR and physically bind to TfR mRNA in the RISC. (A) Schematic layout of TfR mRNA
and presumptive targets of miR-320a and miR-140 via the sequential complementary nucleotides as indicated. The targets and tetranucleotide
mutant targets segments were cloned into a pGL3-control reporter vector. The corresponding mut miR-320 and mut miR-140 were synthesized.
(B) Luciferase activity of lysates of F81 cells after 36 h co-transfection with pGL3-TfR 3′UTR, pRL-TK and miR-320 or miR-140 mimics. NC mimics
were used as controls. (C) Luciferase activity of lysates of F81 cells after 36 h co-transfection with mut320-pGL3-TfR 3′UTR, pRL-TK and miR-320a
or mut miR-320a mimics. NC mimics were used as controls. (D) Luciferase activity of lysates of F81 cells after 36 h co-transfection with mut140-pGL3-
TfR 3′UTR, pRL-TK and miR-140 or mut miR-140 mimics. NC mimics were used as controls. (E) qPCR analysis of TfR mRNA among RNAs extracted from
Ago2 immunoprecipitates or total samples of F81 cells, normalized to β-actin. Data are from 3 independent experiments (mean ± SD). Statistical
significance was analyzed by Student’s t test; *P <0.05; **P <0.01; ***P <0.001; ns, not significant.
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that miR-320a and miR-140 target the 3′UTR of TfR
and physically bind to TfR mRNA in the RISC.
MiR-320a and miR-140 inhibit MEV infection by preventing
the virus from entering cells
Since miR-320a and miR-140 downregulated TfR ex-
pression, we speculated that the two miRNAs could
control MEV infection by preventing the virus from en-
tering cells. To investigate this, F81 cells were trans-
fected with either miR-320a and miR-140 mimics, with
NC mimics as controls. After 48 h transfection, the
cells were infected with MEV (MOI = 0.1). At theindicated times, the quantity of viral genomic DNA was
measured. As predicted, results showed that miR-320a
and miR-140 downregulated the quantity of viral gen-
omic DNA in F81 cells, even during the early stage of
virus infection (Figure 5A). To further validate the re-
sults above, flow cytometry was used to determine the
proportion of MEV-infected cells. Results showed that
compared with transfection with NC mimics, both
miRNAs mimics had a negative effect on MEV-infected
cell numbers from quite early on (Figure 5B,C,D,E).
These results clearly demonstrated that miR-320a and
miR-140 inhibit MEV infection by preventing virus
entry into the cells.
Figure 5 (See legend on next page.)
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(See figure on previous page.)
Figure 5 MiR-320a and miR-140 inhibit MEV infection by preventing the virus to entry into F81 cells. (A) qPCR was used to assess the
effects of miR-320a and miR-140 mimics of MEV genomic DNA at the indicated times after 48 h transfection with the mimics. Data are from 3
independent experiments (mean ± SD). Statistical significance was analyzed by two-way ANOVA test; *P <0.05; **P <0.01; ***P <0.001. (B,C,D,E)
Flow cytometric analysis was used to assess the effects of miR-320a and miR-140 mimics on MEV-infected F81 cells at the indicated times after
48 h transfection with the mimics. The mean fluorescence intensities (MFI) of MEV-infected F81 cells at the indicated times are shown. Data are
from 3 independent experiments (mean ± SD). Statistical significance was analyzed by Student’s t test; *P <0.05; **P <0.01; ***P <0.001.
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synergistic manner
As described above, both miR-320a and miR-140 inhibit
MEV infection by downregulating TfR expression. Since
the targets in TfR 3′UTR of the two miRNAs are different,
we speculated that the two miRNAs could show function
together. To investigate this, F81 cells were transfected
with miR-320a and miR-140 mimics individually or to-
gether, with NC mimics as controls. After 36 h transfec-
tion, TfR mRNAs were assayed by qPCR. Results showedFigure 6 MiR-320a and miR-140 play roles on TfR and MEV in a syner
the relative expression of TfR after 36 h transfection with the mimics, with
the TfR protein levels of lysates of F81 cells after 48 h transfection with the
to assess the effects of the miRNAs on MEV genomic DNA at 12 h post-ME
independent experiments (mean ± SD). Statistical significance was analyzedthat miR-320a and miR140 mimics together decreased
TfR mRNA levels by almost 30% compared to miR-320a
or miR-140 mimics (Figure 6A). At 48 h, western blot
assay also showed that the decrease in TfR protein level
was enhanced by the two miRNAs together (Figure 6B).
To confirm that the two miRNAs also showed greater
negative function on MEV infection, F81 cells were trans-
fected with miR-320a and miR-140 mimics individually or
together, with NC mimics as controls. After 48 h transfec-
tion, the cells were infected with MEV (MOI = 0.1) andgistic manner. (A) qPCR was used to assess effects of the miRNAs on
β-actin as an internal control. (B) Western blot assay was used to assess
miRNAs mimics, with β-actin as an internal control. (C) qPCR was used
V infection, after 48 h transfection with the mimics. Data are from 3
by Student’s t test; *P <0.05; **P <0.01.
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results showed that the two miRNAs together produced a
greater reduction in viral genomic DNA than individually.
Discussion
Host cellular miRNAs have frequently been reported to
interact with viruses during infection [10,15,35-40]. We
recently showed that miR-181b inhibited MEV replica-
tion by repression of its non-structural protein 1 expres-
sion [18]. Here, we report that other miRNAs, miR-320a
and miR-140, inhibit MEV entry into F81 cells by down-
regulating its receptor, TfR, through targeting the 3′UTR
of TfR mRNA.
A number of reports have shown that TfR, as a cell sur-
face receptor, is required for iron delivery to cells. Indeed,
TfR has been established as a gatekeeper for regulating iron
uptake by most cells, and the transferring-to-cell endocytic
pathway has been characterized in detail [41]. TfR is
central to the uptake of iron-loaded transferrin [42] which
is post-transcriptionally regulated via iron-responsive ele-
ments present in its 3′UTR [43]. In addition to its role in
erythropoiesis, TfR is also overexpressed in the majority of
malignancies [44] and is directly linked to cell proliferation
[45-47]. Studies have demonstrated that parvovirus replica-
tion is dependent on host cellular division and proliferation
([48]; Tattersa [49]) and vigorous proliferative activity of
host cells promotes parvoviral replication. Reduction in
cellular metabolic activity, therefore, may explain why
downregulation of TfR inhibits MEV replication. There
may, however, be another mechanism. TfR is necessary for
MEV uptake by host cells: downregulation may thereforeFigure 7 Schematic layout of the mechanism of interaction between
(Up arrows: upregulation; down arrows: downregulation).render infected cells less susceptible to superinfection with
additional MEV particles. While it may take only one vir-
ion to establish a primary infection, a multiply-infected cell
may produce more infectious progeny. Downregulation of
TfR on the cell surface, therefore, may result in diminished
production of virus.
As summarized in Figure 7, MEV infection leads to in-
crease in two host cell miRNAs (miR-320a and miR-140)
which downregulate TfR expression, resulting in a de-
crease in viral replication. Since TfR is a specific receptor
of MEV, however, reduction in it may prevent cellular
entry of further virus following the primary infection,
resulting in protection of host cells from immediate
death as a result of continuing virus infection. Although
two host cell miRNAs were found to be upregulated by
MEV infection, the mechanism remains unclear. We
have identified one mechanism of interaction between
MEV and its host F81 cells, however, that might explain
why a cell can be infected with just one virus.
Since miR-320a and miR-140 have been shown to in-
hibit MEV entry into host cells and might also affect
virus replication, it may find application as an antiviral
therapeutic for MEV-induced mink enteritis. As several
reports have shown [50-54], siRNAs can be used to con-
trol virus diseases in vivo; however, little attention has
so far been paid to the possibility of using endogenous
miRNAs as an antivirus tool. Compared with siRNAs,
endogenous miRNAs may be safer and induce fewer
side-effects. More extensive studies are merited to de-
termine if the two miRNAs described here can be used
as antiviral tools.MEV and its host F81 cells involving two miRNAs and TfR.
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In conclusion, our work has shown that two miRNAs
(miR-320a and miR-140) inhibit MEV entry into the F81
cells by downregulating its specific receptor TfR through
targeting the 3′UTR of TfR mRNA in a synergistic man-
ner, while the two miRNAs were upregulated through
MEV infection. As summarized in Figure 7, a simple
pathway of host-virus interaction network involving TfR
and miRNAs has been deduced. These results provide
further understanding of the mechanisms in MEV infec-
tion and may be helpful for development of endogenous
miRNA antiviral therapy strategies.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JS and WL conceived and designed the experiments. JS performed the
experiments. JS analyzed the data. JS, JW, SW, DY, ZL, BY, QH and YM
contributed reagents/materials/analysis tools. JS and WL wrote the paper.
All authors read and approved the final manuscript.
Acknowledgements
This work was supported by 863 Project (2011AA10A213) and National Key
Scientific Foundation (2009ZX08006-010B).
Received: 15 September 2014 Accepted: 19 November 2014
References
1. Park GS, Best SM, Bloom ME: Two mink parvoviruses use different cellular
receptors for entry into CRFK cells. Virology 2005, 340:1–9.
2. Rivera E, Karlsson KA, Bergman R: The propagation of feline panleukopenia
virus in microcarrier cell-culture and use of the inactivated virus in the
protection of mink against viral-enteritis. Vet Microbiol 1987, 13:371–381.
3. Schofield FW: Virus enteritis in mink. North Amer Vet 1949, 30:651–654.
4. Zhang DL: Studies on isolation, serum-free cultivation and manufacture
of mink enteritis virus optimized for vaccine preparation. Biologicals 1997,
25:103–111.
5. Zuo J, Rao J, Xu H, Ma L, Li B, Wang Y, Cai X, Han W, Lei L, Liu B: Analysis of
the vp2 gene sequence of a new mutated mink enteritis parvovirus
strain in PR China. Virol J 2010, 7:124–129.
6. Ambros V: The functions of animal microRNAs. Nature 2004, 431:350–355.
7. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function.
Cell 2004, 116:281–297.
8. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function
(Reprinted from Cell 116, 281–297, 2004). Cell 2007, 131:11–29.
9. Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA
biogenesis, function and decay. Nat Rev Genet 2010, 11:597–610.
10. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC,
Flemington EK: Epstein-Barr virus latent membrane protein 1 induces
cellular MicroRNA miR-146a, a modulator of lymphocyte signaling
pathways. J Virol 2008, 82:1946–1958.
11. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK: Host-virus
interaction: a new role for microRNAs. Retrovirology 2006, 3:68–76.
12. Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA: A viral
microRNA down-regulates multiple cell cycle genes through mRNA 5′
UTRs. PLoS Pathog 2010, 6:e1000967.
13. Motsch N, Pfuhl T, Mrazek J, Barth S, Graesser FA: Epstein-Barr virus-
encoded latent membrane protein 1 (LMP1) induces the expression of
the cellular microRNA miR-146a. RNA Biol 2007, 4:131–137.
14. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V,
Lalwani M, Pillai B, Mitra D, Brahmachari SK: Human cellular microRNA
hsa-miR-29a interferes with viral nef protein expression and HIV-1
replication. Retrovirology 2008, 5:117–126.
15. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jäker C, Höck J,
Meister G, Grässer FA: Epstein-Barr virus-encoded microRNA miR-BART2down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008,
36:666–675.
16. Lung RWM, Tong JHM, Sung YM, Leung PS, Ng DCH, Chau SL, Chan AWH,
Ng EKO, Lo KW, To KF: Modulation of LMP2A expression by a newly
identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia
2009, 11:1174–U1189.
17. Song L, Liu H, Gao S, Jiang W, Huang W: Cellular microRNAs inhibit
replication of the H1N1 influenza A virus in infected cells. J Virol 2010,
84:8849–8860.
18. Sun JZ, Wang J, Yuan D, Wang S, Li Z, Yi B, Mao Y, Hou Q, Liu W: Cellular
microRNA miR-181b inhibits replication of mink enteritis virus by repression
of non-structural protein 1 translation. PLoS ONE 2013, 8:e81515.
19. Goodman LB, Lyi SM, Johnson NC, Cifuente JO, Hafenstein SL, Parrish CR:
Binding site on the transferrin receptor for the parvovirus capsid and
effects of altered affinity on cell uptake and infection. J Virol 2010,
84:4969–4978.
20. Hueffer K, Govindasamy L, Agbandje-McKenna M, Parrish CR: Combinations
of two capsid regions controlling canine host range determine canine
transferrin receptor binding by canine and feline parvoviruses. J Virol
2003, 77:10099–10105.
21. Hueffer K, Palermo LM, Parrish CR: Parvovirus infection of cells by using
variants of the feline transferrin receptor altering clathrin-mediated
endocytosis, membrane domain localization, and capsid-binding
domains. J Virol 2004, 78:5601–5611.
22. Mellman I: Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 1996,
12:575–625.
23. Palermo LM, Hafenstein SL, Parrish CR: Purified feline and canine
transferrin receptors reveal complex interactions with the capsids of
canine and feline parvoviruses that correspond to their host ranges.
J Virol 2006, 80:8482–8492.
24. Parker JSL, Murphy WJ, Wang D, O’Brien SJ, Parrish CR: Canine and feline
parvoviruses can use human or feline transferrin receptors to bind,
enter, and infect cells. J Virol 2001, 75:3896–3902.
25. Glazov EA, Cottee PA, Barris WC, Moore RJ, Dalrymple BP, Tizard ML: A
microRNA catalog of the developing chicken embryo identified by a
deep sequencing approach. Genome Res 2008, 18:957–964.
26. Pontius JU, Mullikin JC, Smith DR, Lindblad-Toh K, Gnerre S, Clamp M, Chang
J, Stephens R, Neelam B, Volfovsky N, Schäffer AA, Agarwala R, Narfström K,
Murphy WJ, Giger U, Roca AL, Antunes A, Menotti-Raymond M, Yuhki N,
Pecon-Slattery J, Johnson WE, Bourque G, Tesler G, O’Brien SJ, NISC
Comparative Sequencing Program: Initial sequence and comparative
analysis of the cat genome. Genome Res 2007, 17:1675–1689.
27. Pontius JU, O’Brien SJ: Genome annotation resource Fields-GARFIELD: a
genome browser for Felis catus. J Hered 2007, 98:386–389.
28. Li R, Li Y, Kristiansen K, Wang J: SOAP: short oligonucleotide alignment
program. Bioinformatics 2008, 24:713–714.
29. Bland C, Ramsey TL, Sabree F, Lowe M, Brown K, Kyrpides NC, Hugenholtz P:
CRISPR Recognition Tool (CRT): a tool for automatic detection of
clustered regularly interspaced palindromic repeats. BMC Bioinformatics
2007, 8:209–216.
30. Krueger J, Rehmsmeier M: RNAhybrid: microRNA target prediction easy,
fast and flexible. Nucleic Acids Res 2006, 34:W451–W454.
31. Huang HY, Chien CH, Jen KH, Huang HD: RegRNA: an integrated web
server for identifying regulatory RNA motifs and elements. Nucleic Acids
Res 2006, 34:W429–W434.
32. Yang CH, Yue J, Fan M, Pfeffer LM: IFN induces miR-21 through a signal
transducer and activator of transcription 3-dependent pathway as a
suppressive negative feedback on IFN-induced apoptosis. Cancer Res
2010, 70:8108–8116.
33. Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF: High-
throughput real-time quantitative reverse transcription PCR. Curr Protoc
Mol Biol 2006, Chapter 15:Unit 15.8.
34. Sun JZ, Wang J, Wang S, Yuan D, Birame BM, Li Z, Yi B, Liu W: MicroRNA
profile analysis of a feline kidney cell line before and after infection with
mink enteritis virus. Gene 2014, 539:224–229.
35. Otsuka M, Jing Q, Georgel P, New L, Chen J, Mols J, Kang YJ, Jiang Z, Du X,
Cook R, Das SC, Pattnaik AK, Beutler B, Han J: Hypersusceptibility to
vesicular stomatitis virus infection in Dicer1-deficient mice is due to
impaired miR24 and miR93 expression. Immunity 2007, 27:123–134.
36. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, Liu Y, Gong H, Zhu Y,
Liu F, Wu J: A liver-specific microRNA binds to a highly conserved RNA
Sun et al. Virology Journal 2014, 11:210 Page 12 of 12
http://www.virologyj.com/content/11/1/210sequence of hepatitis B virus and negatively regulates viral gene expression
and replication. FASEB J 2011, 25:4511–4521.
37. Huang Y, Shen XJ, Zou QA, Wang SP, Tang SM, Zhang GZ: Biological
functions of microRNAs: a review. J Physiol Biochem 2011, 67:129–139.
38. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C,
Saib A, Voinnet O: A cellular MicroRNA mediates antiviral defense in
human cells. Science 2005, 308:557–560.
39. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM: Cellular microRNA
and P bodies modulate host-HIV-1 interactions. Mol Cell 2009, 34:696–709.
40. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M:
Interferon modulation of cellular microRNAs as an antiviral mechanism.
Nature 2007, 449:919–U913.
41. Aisen P: Transferrin receptor 1. Int J Biochem Cell B 2004, 36:2137–2143.
42. Cheng Y, Zak O, Alsen P, Harrison SC, Walz T: Structure of the human
transferrin receptor-transferrin complex. Cell 2004, 116:565–576.
43. Kwok JC, Richardson DR: The iron metabolism of neoplastic cells:
alterations that facilitate proliferation? Crit Rev Oncol Hemat 2002, 42:65–78.
44. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY: Transferrin
receptors in human-tissues - their distribution and possible clinical
relevance. J Clin Pathol 1983, 36:539–545.
45. Chitambar CR, Massey EJ, Seligman PA: Regulation of transferrin receptor
expression on human-leukemic cells during proliferation and induction
of differentiation - effects of gallium and dimethylsulfoxide. J Clin Invest
1983, 72:1314–1325.
46. Larrick JW, Cresswell P: Modulation of cell-surface iron transferrin receptors by
cellular density and state of activation. J Supramol Struct 1979, 11:579–586.
47. Neckers LM, Trepel JB: Transferrin receptor expression and the control of
cell-growth. Cancer Invest 1986, 4:461–470.
48. Op De Beeck A, Caillet-Fauquet P: Viruses and the cell cycle. Prog Cell Cycle
Res 1997, 3:1–19.
49. Tattersall P: Replication of the parvovirus MVM 1. Dependence of virus
multiplication and plaque-formation on cell-growth. J Virol 1972,
10:586–590.
50. Davidson BL, McCray PB Jr: Current prospects for RNA interference-based
therapies. Nat Rev Genet 2011, 12:329–340.
51. Geisbert TW, Lee ACH, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC,
de Jong S, Tavakoli I, Judge A, Hensley LE, MacLachlan I: Postexposure
protection of non-human primates against a lethal Ebola virus challenge
with RNA interference: a proof-of-concept study. Lancet 2010, 375:1896–1905.
52. Li BJ, Tang QQ, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu YJ, Zheng BJ,
Woodle MC, Zhong NS, Lu PY: Using siRNA in prophylactic and
therapeutic regimens against SARS coronavirus in rhesus macaque.
Nat Med 2005, 11:944–951.
53. Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM,
Lieberman J: An siRNA-based microbicide protects mice from lethal
herpes simplex virus 2 infection. Nature 2006, 439:89–94.
54. Tompkins SM, Lo CY, Tumpey TM, Epstein SL: Protection against lethal
influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci
U S A 2004, 101:8682–8686.
doi:10.1186/s12985-014-0210-3
Cite this article as: Sun et al.: MicroRNA miR-320a and miR-140 inhibit
mink enteritis virus infection by repression of its receptor, feline transferrin
receptor. Virology Journal 2014 11:210.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
